Wealthfront Advisers LLC significantly increased its stake in Amgen Inc. by 22.4% in the third quarter, holding 70,233 shares valued at $19.82 million. Other institutional investors also adjusted their positions in Amgen. Despite a 3.0% stock dip, Amgen reported strong Q4 earnings, beating analyst estimates, and increased its quarterly dividend to $2.52 per share.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN
Wealthfront Advisers LLC significantly increased its stake in Amgen Inc. by 22.4% in the third quarter, holding 70,233 shares valued at $19.82 million. Other institutional investors also adjusted their positions in Amgen. Despite a 3.0% stock dip, Amgen reported strong Q4 earnings, beating analyst estimates, and increased its quarterly dividend to $2.52 per share.